Glooko is the leading diabetes data management and remote patient monitoring platform used by millions of people with diabetes and thousands of clinics worldwide. Our system has generated billions of real-world data points since 2005, enabling providers to analyze data from over 200 diabetes and biometric devices in a single location to improve patient care.… Continue reading Glooko’s Annual Diabetes Data Report – Remote patient monitoring and control trends during the COVID-19 pandemic
Category: COVID-19
How to scale telehealth programs by leveraging diabetes data to identify “at-risk” patients
The expansion in reimbursement coverage for both telehealth and remote patient monitoring (RPM) services offers unique opportunities for delivering enhanced care for patients with diabetes, and many healthcare organizations are seeking to take advantage. For those organizations that are either starting or scaling virtual patient care programs, a common and recurring step in the workflow… Continue reading How to scale telehealth programs by leveraging diabetes data to identify “at-risk” patients
Living with diabetes during the COVID-19 pandemic: A real-world look at how people with diabetes have been impacted
Glooko users show a slight trend toward better glucose control during the pandemic. People with diabetes face a greater chance of experiencing serious complications caused by the coronavirus. To understand the impact of COVID-19 on people with diabetes, we analyzed glucose, insulin, and activity trends from users of Glooko solutions in the United States. We… Continue reading Living with diabetes during the COVID-19 pandemic: A real-world look at how people with diabetes have been impacted
